Categories

VETERINARY PRODUCTS FOR HORSES PHONE SALE  5411 4836 2700

Torbutrol

Torbutrol

TORBUTROL

DESCRIPTION Narcotic analgesic agonist-antagonist with central action, with potent antitussive activity, for use in horses. COMPOSITION Butorphanol tartrate: 1g. Excipients c.s.p: 100 ml. ACTION Butorphanol has been shown to have 5 times more analgesic activity than morphine and is 30 times more potent than pentazocine, with minimal depressant cardiopulmonary effects and without causing histamine release after use, unlike classical agonist analgesics. INDICATIONS Indicated to relieve pain in colic in adult horses and foals one year. Relieves abdominal pain associated with pain, impaction, intussusception, spasmodic and tympanic colic and postpartum pain. CONTRAINDICATIONS Sale product under filed prescription. Like all medicines, keep out of the reach of children. Store in a dry and cool place, between 15 and 30ºC and protected from light. Use with caution when used in combination with other sedatives and analgesics since they can produce additive effects. RESTRICTIONS OF USE Do not use in equines intended for human consumption. SIDE EFFECTS AND ADVERSE REACTIONS Mild cardiopulmonary depressant effect, which is not dose-dependent but reaches a ceiling, above which an increase in dose causes relatively minor depressant effects. There is no evidence to suggest that Butorfanol Tartrate affects fertility or causes harm to the fetus. In equines it has been described: mild transient ataxia and sedation. DOSAGE Administer 0.1 mg per kg of live weight (equivalent to 5 ml per 456 kg) intravenously. The dose can be repeated at 3 or 4 hours, but the treatment should not exceed 48 hours.

  USD77.70
COD: #0020-0031
Categories:  Anesthetics

Share:
TORBUTROL

DESCRIPTION Narcotic analgesic agonist-antagonist with central action, with potent antitussive activity, for use in horses. COMPOSITION Butorphanol tartrate: 1g. Excipients c.s.p: 100 ml. ACTION Butorphanol has been shown to have 5 times more analgesic activity than morphine and is 30 times more potent than pentazocine, with minimal depressant cardiopulmonary effects and without causing histamine release after use, unlike classical agonist analgesics. INDICATIONS Indicated to relieve pain in colic in adult horses and foals one year. Relieves abdominal pain associated with pain, impaction, intussusception, spasmodic and tympanic colic and postpartum pain. CONTRAINDICATIONS Sale product under filed prescription. Like all medicines, keep out of the reach of children. Store in a dry and cool place, between 15 and 30ºC and protected from light. Use with caution when used in combination with other sedatives and analgesics since they can produce additive effects. RESTRICTIONS OF USE Do not use in equines intended for human consumption. SIDE EFFECTS AND ADVERSE REACTIONS Mild cardiopulmonary depressant effect, which is not dose-dependent but reaches a ceiling, above which an increase in dose causes relatively minor depressant effects. There is no evidence to suggest that Butorfanol Tartrate affects fertility or causes harm to the fetus. In equines it has been described: mild transient ataxia and sedation. DOSAGE Administer 0.1 mg per kg of live weight (equivalent to 5 ml per 456 kg) intravenously. The dose can be repeated at 3 or 4 hours, but the treatment should not exceed 48 hours.
Analgesic
Si
20
No
Horses
Si
Argentina